335 related articles for article (PubMed ID: 15931618)
1. Sex difference in development of diabetes and cardiovascular disease on the way from obesity and metabolic syndrome.
Onat A; Hergenç G; Keleş I; Doğan Y; Türkmen S; Sansoy V
Metabolism; 2005 Jun; 54(6):800-8. PubMed ID: 15931618
[TBL] [Abstract][Full Text] [Related]
2. Discordance between insulin resistance and metabolic syndrome: features and associated cardiovascular risk in adults with normal glucose regulation.
Onat A; Hergenç G; Türkmen S; Yazici M; Sari I; Can G
Metabolism; 2006 Apr; 55(4):445-52. PubMed ID: 16546474
[TBL] [Abstract][Full Text] [Related]
3. Plasma triglycerides, an independent predictor of cardiovascular disease in men: a prospective study based on a population with prevalent metabolic syndrome.
Onat A; Sari I; Yazici M; Can G; Hergenç G; Avci GS
Int J Cardiol; 2006 Mar; 108(1):89-95. PubMed ID: 16085325
[TBL] [Abstract][Full Text] [Related]
4. All-cause mortality risk predictors in a preventive cardiology clinic cohort-examining diabetes and individual metabolic syndrome criteria: a PRECIS database study.
Doshi KB; Kashyap SR; Brennan DM; Hoar BM; Cho L; Hoogwerf BJ
Diabetes Obes Metab; 2009 Feb; 11(2):102-8. PubMed ID: 18494803
[TBL] [Abstract][Full Text] [Related]
5. Dyslipidemic hypertension: distinctive features and cardiovascular risk in a prospective population-based study.
Onat A; Hergenç G; Sari I; Türkmen S; Can G; Sansoy V
Am J Hypertens; 2005 Mar; 18(3):409-16. PubMed ID: 15797662
[TBL] [Abstract][Full Text] [Related]
6. Predictors of abdominal obesity and high susceptibility of cardiometabolic risk to its increments among Turkish women: a prospective population-based study.
Onat A; Sari I; Hergenç G; Yazici M; Uyarel H; Can G; Sansoy V
Metabolism; 2007 Mar; 56(3):348-56. PubMed ID: 17292723
[TBL] [Abstract][Full Text] [Related]
7. Metabolic syndrome in Portugal: prevalence and implications for cardiovascular risk--results from the VALSIM Study.
Fiuza M; Cortez-Dias N; Martins S; Belo A;
Rev Port Cardiol; 2008 Dec; 27(12):1495-529. PubMed ID: 19280993
[TBL] [Abstract][Full Text] [Related]
8. Prevalence, incidence, predictors and outcome of type 2 diabetes in Turkey.
Onat A; Hergenç G; Uyarel H; Can G; Ozhan H
Anadolu Kardiyol Derg; 2006 Dec; 6(4):314-21. PubMed ID: 17162275
[TBL] [Abstract][Full Text] [Related]
9. The importance of diagnostic criteria in the association between the metabolic syndrome and cardiovascular disease in obese subjects.
Vidal J; Morínigo R; Codoceo VH; Casamitjana R; Pellitero S; Gomis R
Int J Obes (Lond); 2005 Jun; 29(6):668-74. PubMed ID: 15753955
[TBL] [Abstract][Full Text] [Related]
10. The National Cholesterol Education Program - Adult Treatment Panel III, International Diabetes Federation, and World Health Organization definitions of the metabolic syndrome as predictors of incident cardiovascular disease and diabetes.
Lorenzo C; Williams K; Hunt KJ; Haffner SM
Diabetes Care; 2007 Jan; 30(1):8-13. PubMed ID: 17192325
[TBL] [Abstract][Full Text] [Related]
11. Analysis of criteria for metabolic syndrome in a population-based study of Japanese-Brazilians.
Rosenbaum P; Gimeno SG; Sanudo A; Franco LJ; Ferreira SR;
Diabetes Obes Metab; 2005 Jul; 7(4):352-9. PubMed ID: 15955121
[TBL] [Abstract][Full Text] [Related]
12. Metabolic syndrome as a predictor of cardiovascular diseases and type 2 diabetes in Koreans.
Hwang YC; Jee JH; Oh EY; Choi YH; Lee MS; Kim KW; Lee MK
Int J Cardiol; 2009 May; 134(3):313-21. PubMed ID: 19131127
[TBL] [Abstract][Full Text] [Related]
13. Obesity and abdominal obesity; an alarming challenge for cardio-metabolic risk in Turkish adults.
Oğuz A; Temizhan A; Abaci A; Kozan O; Erol C; Ongen Z; Celik S
Anadolu Kardiyol Derg; 2008 Dec; 8(6):401-6. PubMed ID: 19103534
[TBL] [Abstract][Full Text] [Related]
14. Serum C-reactive protein is an independent risk factor predicting cardiometabolic risk.
Onat A; Can G; Hergenç G
Metabolism; 2008 Feb; 57(2):207-14. PubMed ID: 18191050
[TBL] [Abstract][Full Text] [Related]
15. Serum sex hormone-binding globulin, a determinant of cardiometabolic disorders independent of abdominal obesity and insulin resistance in elderly men and women.
Onat A; Hergenç G; Karabulut A; Albayrak S; Can G; Kaya Z
Metabolism; 2007 Oct; 56(10):1356-62. PubMed ID: 17884445
[TBL] [Abstract][Full Text] [Related]
16. Ten-year cardiovascular disease risk of metabolic syndrome without central obesity in middle-aged chinese.
Zhao D; Grundy SM; Wang W; Liu J; Zeng Z; Wang W; Wu Z
Am J Cardiol; 2007 Sep; 100(5):835-9. PubMed ID: 17719329
[TBL] [Abstract][Full Text] [Related]
17. Impact of metabolic syndrome, diabetes and prediabetes on cardiovascular events: Tehran lipid and glucose study.
Hadaegh F; Shafiee G; Ghasemi A; Sarbakhsh P; Azizi F
Diabetes Res Clin Pract; 2010 Mar; 87(3):342-7. PubMed ID: 20004035
[TBL] [Abstract][Full Text] [Related]
18. Association of body mass index, metabolic syndrome, and leukocyte count.
Desai MY; Dalal D; Santos RD; Carvalho JA; Nasir K; Blumenthal RS
Am J Cardiol; 2006 Mar; 97(6):835-8. PubMed ID: 16516585
[TBL] [Abstract][Full Text] [Related]
19. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults.
Malik S; Wong ND; Franklin SS; Kamath TV; L'Italien GJ; Pio JR; Williams GR
Circulation; 2004 Sep; 110(10):1245-50. PubMed ID: 15326067
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of metabolic syndrome in heart transplant patients: role of previous cardiopathy and years since the procedure--the TRACA study.
Cordero Fort A; Gavira JJ; Alegría-Barrero E; Castaño S; Martín A; Ubilla M; Mastrobuoni S; Alegría Ezquerra E; Herreros J; Rábago G
J Heart Lung Transplant; 2006 Oct; 25(10):1192-8. PubMed ID: 17045931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
